| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
|
Int J Cancer
|
2004
|
1.95
|
|
2
|
Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
|
Cancer
|
2003
|
1.74
|
|
3
|
Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.
|
BMC Cancer
|
2010
|
1.13
|
|
4
|
Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis.
|
Oncol Rep
|
2008
|
1.12
|
|
5
|
ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
|
Clin Cancer Res
|
2008
|
1.11
|
|
6
|
Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma.
|
Clin Cancer Res
|
2007
|
1.05
|
|
7
|
Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
|
Ann Surg Oncol
|
2007
|
1.04
|
|
8
|
Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.
|
Am J Pathol
|
2002
|
1.01
|
|
9
|
Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.
|
J Gastrointest Surg
|
2011
|
0.91
|
|
10
|
S100P expression is a novel prognostic factor in hepatocellular carcinoma and predicts survival in patients with high tumor stage or early recurrent tumors.
|
PLoS One
|
2013
|
0.86
|
|
11
|
Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma.
|
Langenbecks Arch Surg
|
2015
|
0.81
|
|
12
|
Aberrant expressions of annexin A10 short isoform, osteopontin and alpha-fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma.
|
Int J Oncol
|
2005
|
0.79
|
|
13
|
Expression of bile duct transcription factor HNF1β predicts early tumor recurrence and is a stage-independent prognostic factor in hepatocellular carcinoma.
|
J Gastrointest Surg
|
2014
|
0.79
|
|
14
|
Expression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinoma.
|
Int J Surg
|
2012
|
0.78
|
|
15
|
Expression and prognostic significance of gastric-specific annexin A10 in diffuse- and intestinal-type gastric carcinoma.
|
J Gastroenterol Hepatol
|
2011
|
0.77
|